D. E. Shaw & Co., Inc. - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2014$148,000
-13.5%
166,255
+9.2%
0.00%
Q2 2014$171,000
+1.2%
152,292
+10.2%
0.00%
Q1 2014$169,000
+50.9%
138,192
+14.4%
0.00%
Q4 2013$112,000
-71.4%
120,827
-40.0%
0.00%
-100.0%
Q2 2013$391,000201,4970.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders